(Q40274279)

19 September 2017

Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus (English)

1 reference

19 September 2017

0 references

Ernesto Marcos

1

1 reference

19 September 2017

Lázaro Gil

2

1 reference

19 September 2017

Laura Lazo

3

1 reference

19 September 2017

Alienys Izquierdo

4

1 reference

19 September 2017

Enma Brown

5

1 reference

19 September 2017

Edith Suzarte

6

1 reference

19 September 2017

Iris Valdés

7

1 reference

19 September 2017

Angélica García

8

1 reference

19 September 2017

Lissandra Méndez

9

1 reference

19 September 2017

María G Guzmán

10

1 reference

19 September 2017

Gerardo Guillén

11

1 reference

19 September 2017

Lisset Hermida

12

1 reference

19 September 2017

18 September 2012

1 reference

19 September 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Archives of Virology

1 reference

19 September 2017

158

1 reference

19 September 2017

225-230

1 reference

19 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00705-012-1471-z

19 September 2017

0 references

cites work

Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Mouse models of dengue virus infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Technical and regulatory hurdles for DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-012-1471-Z

10.1007/S00705-012-1471-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference